| Audio Interview: Covid-19 and the President #MMPMID33027580Rubin EJ; Baden LR; Morrissey SN Engl J Med 2020[Oct]; 383 (15): e104 PMID33027580show ga
ä|*Betacoronavirus/drug effects/physiology[MESH]|*Government Employees[MESH]|Adenosine Monophosphate/analogs & derivatives/therapeutic use[MESH]|Alanine/analogs & derivatives/therapeutic use[MESH]|Antibodies, Monoclonal/therapeutic use[MESH]|Antiviral Agents/adverse effects/*therapeutic use[MESH]|COVID-19[MESH]|COVID-19 Serotherapy[MESH]|Coronavirus Infections/complications/epidemiology/*therapy[MESH]|Dexamethasone/adverse effects/*therapeutic use[MESH]|Drug Administration Schedule[MESH]|Drug Therapy, Combination[MESH]|Federal Government[MESH]|Glucocorticoids/adverse effects/*therapeutic use[MESH]|HIV Protease Inhibitors/therapeutic use[MESH]|Humans[MESH]|Hypoxia/etiology/therapy[MESH]|Immunization, Passive[MESH]|Lopinavir/therapeutic use[MESH]|Oxygen Inhalation Therapy[MESH]|Pandemics[MESH]|Patient Acuity[MESH]|Pneumonia, Viral/complications/epidemiology/*therapy[MESH]|Risk Assessment[MESH]|SARS-CoV-2[MESH]|United States/epidemiology[MESH]
DeepDyve Pubget Overpricing |
|